Weight-loss drug delayed
US health regulators have delayed their decision on whether to approve Sanofi-Aventis' highly anticipated weight loss drug, Acomplia.
Read the rest of this entry ... (87 words left)
US health regulators have delayed their decision on whether to approve Sanofi-Aventis' highly anticipated weight loss drug, Acomplia.
Read the rest of this entry ... (87 words left)